Evidence map›Paper›PMID 34369225›Full record

ArticleNutrition and cancer2022

Association of Sugar Intake with Inflammation- and Angiogenesis-Related Biomarkers in Newly Diagnosed Colorectal Cancer Patients.

Kelly L Stewart, Biljana Gigic, Caroline Himbert, Christy A Warby, Jennifer Ose, Tengda Lin, Petra Schrotz-King, Jürgen Boehm, Kristine C Jordan, Julie Metos and 8 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Nutrition and cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02328677 (ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02328677 recruitingnot on this map

ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis

TypeobservationalSponsorUniversity of UtahRan2007 to 2030Enrolled5,000ConditionsColorectal Cancer
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Role of dietary nutrients and metabolism in colorectal cancer.Asia Pacific journal of clinical nutrition · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Associations of Individual and Combined Physical Activity and Body Mass Index Groups with Proinflammatory Biomarkers among Colorectal Cancer Patients.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  7. Presurgery Adhesion Molecules and Angiogenesis Biomarkers Are Differently Associated with Outcomes in Colon and Rectal Cancer: Results from the ColoCare Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 2 countries.

Kelly L StewartDepartment of Nutrition and Integrated Physiology, University of Utah, Salt Lake City, United States.
Biljana GigicDepartment of General, Visceral, and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Caroline HimbertHuntsman Cancer Institute, Population Sciences, Salt Lake City, Utah.
Christy A WarbyDepartment of Population Health Sciences, University of Utah, Salt Lake City, Utah.
Jennifer OseHuntsman Cancer Institute, Population Sciences, Salt Lake City, Utah.
Tengda LinHuntsman Cancer Institute, Population Sciences, Salt Lake City, Utah.
Petra Schrotz-KingDivision of Preventive Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Jürgen BoehmHuntsman Cancer Institute, Population Sciences, Salt Lake City, Utah.
Kristine C JordanDepartment of Nutrition and Integrated Physiology, University of Utah, Salt Lake City, United States.ORCID 0000-0002-0688-6514
Julie MetosDepartment of Nutrition and Integrated Physiology, University of Utah, Salt Lake City, United States.ORCID 0000-0003-4531-7725
Martin SchneiderDepartment of General, Visceral, and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Jane C FigueiredoCedars-Sinai Medical Center, Los Angeles, California, USA.
Christopher I LiFred Hutchinson Cancer Research Center, Seattle, Washington, USA.
David ShibataThe University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Erin SiegelH. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Adetunji T ToriolaSchool of Medicine, Washington University, St. Louis, Missouri, USA.
Sheetal HardikarHuntsman Cancer Institute, Population Sciences, Salt Lake City, Utah.
Cornelia M UlrichHuntsman Cancer Institute, Population Sciences, Salt Lake City, Utah.
University of Utah · USHeidelberg University · DECedars-Sinai Medical Center · USFred Hutch Cancer Center · USGerman Cancer Research Center · DEMoffitt Cancer Center · USUniversity of Tennessee Health Science Center · USWashington University in St. Louis · US

Funding

Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare StudyU01CA206110 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jane C. Figueiredo, Christopher I Li · 2016 to 2026
$18.6M
Discovery and verification of novel biomarkers of colorectal cancer recurrenceR01CA189184 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LI, CHRISTOPHER I, ULRICH, CORNELIA M · 2015 to 2020
$5.6M
Metabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer RecurrenceR01CA207371 · NCI · UNIVERSITY OF UTAH · PI LI, CHRISTOPHER I, ULRICH, CORNELIA M · 2017 to 2022
$3.9M
Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP StudyR01CA211705 · NCI · UNIVERSITY OF UTAH · PI LASTAYO, PAUL C, ULRICH, CORNELIA M · 2017 to 2021
$2.2M
Diabetes, Medications and the Cost-Effectiveness of Screening for Colorectal NeoplasiaK07CA222060 · NCI · UNIVERSITY OF UTAH · PI HARDIKAR, SHEETAL · 2018 to 2022
$791k
NCI NIH HHS K07 CA222060NCI NIH HHS R01 CA189184NCI NIH HHS R01 CA207371NCI NIH HHS R01 CA211705NCI NIH HHS U01 CA206110
6 · The paper itself

Abstract

Evidence suggests a positive association between sugar intake and colorectal cancer (CRC) outcomes. We sought to investigate inflammation and angiogenesis as underlying mechanisms behind increased sugar intake and worse CRC outcomes. Pre-surgery serum samples were obtained from 191 patients diagnosed with primary invasive stage I-IV CRC. Biomarkers of inflammation (CRP, SAA, IL-6, IL-8, MCP-1, TNFα) and angiogenesis (VEGFA, VEGFD, sICAM-1 and sVCAM-1) were analyzed (Meso-Scale-Discovery). Fructose, glucose, sucrose, and total sugar intake (calories/day, % total calories) were assessed by FFQ. Pearson's correlation and multiple linear regression analyses were performed. Patients were on average 64 years old, 64% were male, the majority was diagnosed with stage II-III (58%) cancers, and 67% were either overweight or obese. Among normal-weight individuals (BMI <25 kg/m

Indexed as

Colorectal NeoplasmsInflammationBiomarkersFemaleFructoseGlucoseHumansMaleMiddle AgedNeovascularization, PathologicObesitySucroseBiomarkersFructoseGlucoseSucrose

Identifiers

PMID34369225
PMCPMC8825879
OpenAlexW3191348230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.